AAPL   323.34 (+0.46%)
MSFT   184.91 (+1.14%)
FB   232.72 (+0.35%)
GOOGL   1,442.31 (+0.52%)
AMZN   2,472.41 (+0.06%)
NVDA   353.01 (+0.22%)
CGC   16.14 (-2.06%)
BABA   214.33 (+3.76%)
MU   46.82 (+1.04%)
GE   7.05 (+4.29%)
TSLA   881.56 (-1.84%)
AMD   53.54 (-0.17%)
T   30.99 (+0.19%)
ACB   14.53 (+3.05%)
F   5.90 (+0.51%)
GILD   73.26 (-2.53%)
DIS   118.75 (-0.02%)
NFLX   427.31 (+0.33%)
BAC   24.84 (+0.93%)
BA   153.31 (+1.27%)
AAPL   323.34 (+0.46%)
MSFT   184.91 (+1.14%)
FB   232.72 (+0.35%)
GOOGL   1,442.31 (+0.52%)
AMZN   2,472.41 (+0.06%)
NVDA   353.01 (+0.22%)
CGC   16.14 (-2.06%)
BABA   214.33 (+3.76%)
MU   46.82 (+1.04%)
GE   7.05 (+4.29%)
TSLA   881.56 (-1.84%)
AMD   53.54 (-0.17%)
T   30.99 (+0.19%)
ACB   14.53 (+3.05%)
F   5.90 (+0.51%)
GILD   73.26 (-2.53%)
DIS   118.75 (-0.02%)
NFLX   427.31 (+0.33%)
BAC   24.84 (+0.93%)
BA   153.31 (+1.27%)
AAPL   323.34 (+0.46%)
MSFT   184.91 (+1.14%)
FB   232.72 (+0.35%)
GOOGL   1,442.31 (+0.52%)
AMZN   2,472.41 (+0.06%)
NVDA   353.01 (+0.22%)
CGC   16.14 (-2.06%)
BABA   214.33 (+3.76%)
MU   46.82 (+1.04%)
GE   7.05 (+4.29%)
TSLA   881.56 (-1.84%)
AMD   53.54 (-0.17%)
T   30.99 (+0.19%)
ACB   14.53 (+3.05%)
F   5.90 (+0.51%)
GILD   73.26 (-2.53%)
DIS   118.75 (-0.02%)
NFLX   427.31 (+0.33%)
BAC   24.84 (+0.93%)
BA   153.31 (+1.27%)
AAPL   323.34 (+0.46%)
MSFT   184.91 (+1.14%)
FB   232.72 (+0.35%)
GOOGL   1,442.31 (+0.52%)
AMZN   2,472.41 (+0.06%)
NVDA   353.01 (+0.22%)
CGC   16.14 (-2.06%)
BABA   214.33 (+3.76%)
MU   46.82 (+1.04%)
GE   7.05 (+4.29%)
TSLA   881.56 (-1.84%)
AMD   53.54 (-0.17%)
T   30.99 (+0.19%)
ACB   14.53 (+3.05%)
F   5.90 (+0.51%)
GILD   73.26 (-2.53%)
DIS   118.75 (-0.02%)
NFLX   427.31 (+0.33%)
BAC   24.84 (+0.93%)
BA   153.31 (+1.27%)
Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 Kala PharmaceuticalsFlexion TherapeuticsWave Life SciencesDynavax TechnologiesDURECT
SymbolNASDAQ:KALANASDAQ:FLXNNASDAQ:WVENASDAQ:DVAXNASDAQ:DRRX
Price Information
Current Price$13.79$12.18$9.57$7.18$2.44
52 Week RangeBuyBuyBuyBuyBuy
Beat the Market™ Rank
Overall Score2.32.41.72.11.6
Analysis Score4.54.63.33.53.4
Community Score2.63.02.72.53.0
Dividend Score0.00.00.00.00.0
Ownership Score4.04.02.04.01.0
Earnings & Valuation Score0.60.60.60.60.6
Analyst Ratings
Consensus RecommendationBuyBuyBuyBuyBuy
Consensus Price Target$21.40$23.33$28.00$16.00$4.53
% Upside from Price Target55.18% upside91.57% upside192.58% upside122.84% upside85.45% upside
Trade Information
Market Cap$671.79 million$438.43 million$348.55 million$679.27 million$480.25 million
Beta0.362.060.021.142.2
Average Volume1,260,826873,931654,2803,256,3931,334,094
Sales & Book Value
Annual Revenue$6.07 million$72.96 million$15.98 million$35.22 million$29.56 million
Price / Sales123.986.4420.9018.7916.18
CashflowN/AN/AN/AN/AN/A
Price / CashN/AN/AN/AN/AN/A
Book Value$0.86 per share($0.53) per share$1.86 per share$0.10 per share$0.12 per share
Price / Book16.03-22.985.1571.8020.33
Profitability
Net Income$-94,350,000.00$-149,770,000.00$-193,640,000.00$-152,600,000.00$-20,580,000.00
EPS($2.76)($3.93)($5.72)($1.87)($0.12)
Trailing P/E RatioN/AN/AN/AN/AN/A
Forward P/E RatioN/AN/AN/AN/AN/A
P/E GrowthN/AN/AN/AN/AN/A
Net Margins-1,578.64%-175.76%-1,150.43%-310.97%-82.94%
Return on Equity (ROE)-132.08%-592.50%-219.06%-722.75%-114.36%
Return on Assets (ROA)-48.31%-64.53%-62.74%-45.63%-30.35%
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity Ratio0.50%27.76%1.36%18.31%1.75%
Current Ratio12.17%5.08%1.26%6.63%2.57%
Quick Ratio11.87%4.52%1.26%4.99%2.43%
Ownership Information
Institutional Ownership Percentage73.60%83.08%86.22%67.05%49.93%
Insider Ownership Percentage30.77%16.01%39.70%13.33%10.20%
Miscellaneous
Employees13628825023188
Shares Outstanding54.57 million38.56 million34.89 million92.18 million196.03 million
Next Earnings Date8/4/2020 (Estimated)8/4/2020 (Estimated)8/3/2020 (Estimated)8/5/2020 (Estimated)8/6/2020 (Estimated)
OptionableOptionableOptionableOptionableOptionableOptionable

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.